Overview

PAXIL CR Bioequivalence Study

Status:
Completed
Trial end date:
2008-09-16
Target enrollment:
Participant gender:
Summary
This study is to determine if controlled release paroxetine tablets manufactured at two different sites behave similarly in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Paroxetine